Linda Björkhem-Bergman, Per Fürst, Staffan Lundstrom
{"title":"瑞典姑息性镇静：专科姑息治疗全国调查。","authors":"Linda Björkhem-Bergman, Per Fürst, Staffan Lundstrom","doi":"10.1136/spcare-2025-005618","DOIUrl":null,"url":null,"abstract":"<p><strong>Objectives: </strong>The aim of this study was to map the use of palliative sedation (PS) in specialised palliative care (SPC) in Sweden and compare the results with a survey made 20 years ago.</p><p><strong>Methods: </strong>A survey to all SPC units in Sweden was performed during the first quarter of 2025 as add-on questions to the Swedish Register of Palliative Care. The definition of PS was continuous sedation in the final stage of life with the aim of lowering the patient's consciousness due to intractable symptoms. Questions included whether the patient had received PS (yes/no), choice of drug and how long the sedation lasted.</p><p><strong>Results: </strong>Of 2701 deaths in SPC during the study period, 2069 cases had answered the survey (response rate 77%). Of these, 208 had received PS (10%). The majority of patients had received midazolam as the main sedative, n=185 (89%). Other drugs used as main sedatives were levomepromazine, n=14 (7%); propofol, n=5 (2%); and haloperidol, n=2 (1%). The median duration of sedation was 2 days and 4% had sedation longer than 7 days.</p><p><strong>Conclusions: </strong>PS is more common in Sweden today than 20 years ago, 10% compared to 1%. The vast majority received midazolam as a sedative.</p>","PeriodicalId":9136,"journal":{"name":"BMJ Supportive & Palliative Care","volume":" ","pages":""},"PeriodicalIF":2.0000,"publicationDate":"2025-07-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Palliative sedation in Sweden: specialised palliative care nationwide survey.\",\"authors\":\"Linda Björkhem-Bergman, Per Fürst, Staffan Lundstrom\",\"doi\":\"10.1136/spcare-2025-005618\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Objectives: </strong>The aim of this study was to map the use of palliative sedation (PS) in specialised palliative care (SPC) in Sweden and compare the results with a survey made 20 years ago.</p><p><strong>Methods: </strong>A survey to all SPC units in Sweden was performed during the first quarter of 2025 as add-on questions to the Swedish Register of Palliative Care. The definition of PS was continuous sedation in the final stage of life with the aim of lowering the patient's consciousness due to intractable symptoms. Questions included whether the patient had received PS (yes/no), choice of drug and how long the sedation lasted.</p><p><strong>Results: </strong>Of 2701 deaths in SPC during the study period, 2069 cases had answered the survey (response rate 77%). Of these, 208 had received PS (10%). The majority of patients had received midazolam as the main sedative, n=185 (89%). Other drugs used as main sedatives were levomepromazine, n=14 (7%); propofol, n=5 (2%); and haloperidol, n=2 (1%). The median duration of sedation was 2 days and 4% had sedation longer than 7 days.</p><p><strong>Conclusions: </strong>PS is more common in Sweden today than 20 years ago, 10% compared to 1%. The vast majority received midazolam as a sedative.</p>\",\"PeriodicalId\":9136,\"journal\":{\"name\":\"BMJ Supportive & Palliative Care\",\"volume\":\" \",\"pages\":\"\"},\"PeriodicalIF\":2.0000,\"publicationDate\":\"2025-07-18\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"BMJ Supportive & Palliative Care\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1136/spcare-2025-005618\",\"RegionNum\":4,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q3\",\"JCRName\":\"HEALTH CARE SCIENCES & SERVICES\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"BMJ Supportive & Palliative Care","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1136/spcare-2025-005618","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"HEALTH CARE SCIENCES & SERVICES","Score":null,"Total":0}
Palliative sedation in Sweden: specialised palliative care nationwide survey.
Objectives: The aim of this study was to map the use of palliative sedation (PS) in specialised palliative care (SPC) in Sweden and compare the results with a survey made 20 years ago.
Methods: A survey to all SPC units in Sweden was performed during the first quarter of 2025 as add-on questions to the Swedish Register of Palliative Care. The definition of PS was continuous sedation in the final stage of life with the aim of lowering the patient's consciousness due to intractable symptoms. Questions included whether the patient had received PS (yes/no), choice of drug and how long the sedation lasted.
Results: Of 2701 deaths in SPC during the study period, 2069 cases had answered the survey (response rate 77%). Of these, 208 had received PS (10%). The majority of patients had received midazolam as the main sedative, n=185 (89%). Other drugs used as main sedatives were levomepromazine, n=14 (7%); propofol, n=5 (2%); and haloperidol, n=2 (1%). The median duration of sedation was 2 days and 4% had sedation longer than 7 days.
Conclusions: PS is more common in Sweden today than 20 years ago, 10% compared to 1%. The vast majority received midazolam as a sedative.
期刊介绍：
Published quarterly in print and continuously online, BMJ Supportive & Palliative Care aims to connect many disciplines and specialties throughout the world by providing high quality, clinically relevant research, reviews, comment, information and news of international importance.
We hold an inclusive view of supportive and palliative care research and we are able to call on expertise to critique the whole range of methodologies within the subject, including those working in transitional research, clinical trials, epidemiology, behavioural sciences, ethics and health service research. Articles with relevance to clinical practice and clinical service development will be considered for publication.
In an international context, many different categories of clinician and healthcare workers do clinical work associated with palliative medicine, specialist or generalist palliative care, supportive care, psychosocial-oncology and end of life care. We wish to engage many specialties, not only those traditionally associated with supportive and palliative care. We hope to extend the readership to doctors, nurses, other healthcare workers and researchers in medical and surgical specialties, including but not limited to cardiology, gastroenterology, geriatrics, neurology, oncology, paediatrics, primary care, psychiatry, psychology, renal medicine, respiratory medicine.
求助内容：
应助结果提醒方式：
京公网安备 11010802042870号
